Cardiovascular Diseases (CVD)CAMCONCT06941597

Comparison of Two Gait Re-training Modalities During a Cardiac Rehabilitation Stay: Benefit of Orienteering Walking

An observational study of Cardiovascular Diseases (CVD) and Coronary Heart Disease (CHD), run by Fondation Ildys at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Cardiovascular disease (CVD) is the leading cause of death in France for women and the second leading cause of death for men after cancer. They cause around 140,000 deaths every year, or almost 400 people every day throughout France. Read more about this study

Who is it for?: Ages 18 years and older
Conditions the study is for: Cardiovascular Diseases (CVD), Coronary Heart Disease (CHD), Heart Failure
How many people: 40 participants
Where: 1 siteFrance
Study dates: 28 Apr 2025to 5 Oct 2025
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Study population: The participants are patients undergoing cardiac rehabilitation in the SSR cardiology department of the Ildys Foundation on the Ty Yann site.

Who may be able to join

Patients with stabilised heart disease, coronary artery disease, heart failure, post-operative stay after cardiac surgery, congenital heart disease, patients at high cardiovascular risk and obliterative arteritis of the lower limbs;
Who have been informed and do not object to the study;
Over 18 years of age;
Participating in a cardiac rehabilitation programme;
With a walking distance of less than 3,600 metres;
Able to understand and comply with the requirements of the protocol.

Who cannot join

Pregnant or breast-feeding women
Persons under guardianship or trusteeship

Trial locations and contacts

1 site in 1 country.

France1 site

Fondation ILDYS, Site de Ty Yann
Brest

Other trials in France

About this study

At present, cardiovascular rehabilitation centres mainly use exercise training methods based on sessions on cycloergometers and active walking (walking on a track and/or treadmill). Convinced of the added value of Orienteering, we have included it in our routine treatment as part of our Cardiac Rehabilitation programme, in addition to sessions on cycloergometers and active walking since 2021. As there is little literature on the subject in our population of interest, the aim of this study is to provide evidence of the relevance of orienteering in the cardiac rehabilitation programme.

We hypothesise that orienteering induces a similar cardiac response, amount of physical activity and perception of symptoms compared with an active walking session, while providing greater enjoyment of the activity.

Conditions: Cardiovascular Diseases (CVD), Coronary Heart Disease (CHD), Heart Failure, Congenital Heart Disease
Keywords: cardiovascular diseases, cardiac rehabilitation, active walking, orienteering, heart rate
Medical subject headings: Cardiovascular Diseases, Coronary Disease, Heart Failure, Heart Defects, Congenital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06941597
Study group	Role	What they receive
cardiac rehabilitation group		The management of patients included in this study is unchanged from that usually recommended. The patients included in the study will undergo the same rehabilitation sessions during their stay as patients coming to the centre as a matter of routine. In total, 3 sessions of active walking, 3 sessions of orienteering and 7 sessions of ergocycles were carried out during the stay. The cardiac rehabilitation programme lasted 3 weeks, and all the sessions evaluated as part of the study (active walking, orienteering and ergocycles) were carried out during the last two weeks of the rehabilitation course. For each activity (active walking and orienteering), a familiarisation session will be carried out before the session evaluated as part of the study. The order in which the orientation walking and active walking sessions are carried out will depend on the weeks in which the subjects are included, and may vary according to the organisation of the centre.

What is being measured

The primary outcome is the main question the study is designed to answer.

To compare the average heart rate between an active walking session and an orientation walking session during the cardiac rehabilitation stay.
Average heart rate measured during the active walking session and the orienteering race.
Measured: once during the second and third week of cardiac rehabilitation

Secondary outcomes (9)

To compare the intensity of effort between the active walking, orienteering and cycloergometer sessions.
The maximum heart rate (bpm) will be collected for each of the three sessions.
Measured: once during the second and third week of cardiac rehabilitation
To compare the intensity of effort between the active walking, orienteering and cycloergometer sessions.
The effort intensity score will be collected for each of the 3 sessions on a Borg scale (0-10). The modified Borg scale, also known as the CR10, is a simplified version of the original scale. It comprises 11 levels of perceived effort, ranging from 0 (no effort) to 10 (maximum effort).
Measured: once during the second and third week of cardiac rehabilitation
Compare the performance of the physical activity performed during the active walking versus orienteering session.
Physical activity performance will be measured for each session by the total number of steps taken during active walking and orienteering.
Measured: once during the second and third week of cardiac rehabilitation
Compare the performance of the physical activity performed during the active walking versus orienteering session.
Physical activity performance will be measured for each session by the time spent in the different intensity levels (light, moderate, vigorous) (in minutes and as a percentage).
Measured: once during the second and third week of cardiac rehabilitation
Compare the performance of the physical activity performed during the active walking versus orienteering session.
Physical activity performance will be measured for each session by the distance covered in kilometres.
Measured: once during the second and third week of cardiac rehabilitation
Compare the perception of effort between the active walking, orienteering and cycloergometer sessions.
Perceived motivation to carry out the activity using a Likert scale from 0 to 5. The Likert scale is a semantic scoring system, generally made up of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.
Measured: once during the second and third week of cardiac rehabilitation
Compare the sensation of pleasure between the active walking, orienteering and cycloergometer sessions.
The feeling of pleasure for the three activity sessions will be measured on a Likert scale from 0 to 5. The Likert scale is a semantic rating system, generally composed of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.
Measured: once during the second and third week of cardiac rehabilitation
To compare the desire to continue physical activity between the active walking, orienteering and cycloergometer sessions.
The desire to continue physical activity between the three physical activities will be measured by a Likert scale from 0 to 5. The Likert scale is a semantic rating system, generally composed of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.
Measured: once during the second and third week of cardiac rehabilitation
Compare the heart rate kinetics during the three sessions (orienteering, active walking and cycloergometer).
Changes in heart rate over the three sessions (recorded every 5 minutes for 50 minutes for each session)
Measured: once during the second and third week of cardiac rehabilitation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

28 Apr 20255 Oct 2025

First posted24 Apr 2025
Study start28 Apr 2025
Primary completion5 Oct 2025
Study completion5 Oct 2025

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Cardiovascular Diseases (CVD)Studies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Case-control
Time perspective: Prospective
Enrolment: 40 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT06941597
Sponsor's protocol ID: RI2024_018
Acronym: CAMCO
Status last verified: Apr 2025
First submitted: 16 Apr 2025
Last updated: 24 Dec 2025
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)

All Cardiovascular Diseases (CVD) trials

Study at a glance

From the registry record, last updated by the sponsor on 24 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Comparison of Two Gait Re-training Modalities During a Cardiac Rehabilitation Stay: Benefit of Orienteering Walking
ClinicalTrials.gov ID: NCT06941597
Acronym / sponsor ID: CAMCO / RI2024_018
Conditions: Cardiovascular Diseases (CVD), Coronary Heart Disease (CHD), Heart Failure, Congenital Heart Disease
Keywords: cardiovascular diseases, cardiac rehabilitation, active walking, orienteering, heart rate
Study type: Observational
Recruitment status: Completed
Enrolment: 40 participants (actual)
Lead sponsor: Fondation IldysUniversity, hospital or other
Collaborators: Univ Brest, Laboratory ORPHY, F-29200 Brest, France
Study start: 28 Apr 2025 (actual)
Primary completion: 5 Oct 2025 (actual)
Study completion: 5 Oct 2025 (actual)
First posted: 24 Apr 2025 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Observational model: Case-control
Time perspective: Prospective
Number of arms: 1

Arm	Type	Receives
cardiac rehabilitation group	–	–The management of patients included in this study is unchanged from that usually recommended. The patients included in the study will undergo the same rehabilitation sessions during their stay as patients coming to the centre as a matter of routine. In total, 3 sessions of active walking, 3 sessions of orienteering and 7 sessions of ergocycles were carried out during the stay. The cardiac rehabilitation programme lasted 3 weeks, and all the sessions evaluated as part of the study (active walking, orienteering and ergocycles) were carried out during the last two weeks of the rehabilitation course. For each activity (active walking and orienteering), a familiarisation session will be carried out before the session evaluated as part of the study. The order in which the orientation walking and active walking sessions are carried out will depend on the weeks in which the subjects are included, and may vary according to the organisation of the centre.

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult
Study population: The participants are patients undergoing cardiac rehabilitation in the SSR cardiology department of the Ildys Foundation on the Ty Yann site.

Key inclusion criteria (6 listed)

Patients with stabilised heart disease, coronary artery disease, heart failure, post-operative stay after cardiac surgery, congenital heart disease, patients at high cardiovascular risk and obliterative arteritis of the lower limbs;
Who have been informed and do not object to the study;
Over 18 years of age;
Participating in a cardiac rehabilitation programme;
With a walking distance of less than 3,600 metres;

Key exclusion criteria (2 listed)

Pregnant or breast-feeding women
Persons under guardianship or trusteeship

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

To compare the average heart rate between an active walking session and an orientation walking session during the cardiac rehabilitation stay.
Time frame: once during the second and third week of cardiac rehabilitation
Average heart rate measured during the active walking session and the orienteering race.

9 secondary outcomes

To compare the intensity of effort between the active walking, orienteering and cycloergometer sessions.
Time frame: once during the second and third week of cardiac rehabilitation
To compare the intensity of effort between the active walking, orienteering and cycloergometer sessions.
Time frame: once during the second and third week of cardiac rehabilitation
Compare the performance of the physical activity performed during the active walking versus orienteering session.
Time frame: once during the second and third week of cardiac rehabilitation
Compare the performance of the physical activity performed during the active walking versus orienteering session.
Time frame: once during the second and third week of cardiac rehabilitation
Compare the performance of the physical activity performed during the active walking versus orienteering session.
Time frame: once during the second and third week of cardiac rehabilitation
Compare the perception of effort between the active walking, orienteering and cycloergometer sessions.
Time frame: once during the second and third week of cardiac rehabilitation
Compare the sensation of pleasure between the active walking, orienteering and cycloergometer sessions.
Time frame: once during the second and third week of cardiac rehabilitation
To compare the desire to continue physical activity between the active walking, orienteering and cycloergometer sessions.
Time frame: once during the second and third week of cardiac rehabilitation
Compare the heart rate kinetics during the three sessions (orienteering, active walking and cycloergometer).
Time frame: once during the second and third week of cardiac rehabilitation

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 24 Dec 2025.

Related trials for Cardiovascular Diseases (CVD)

Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Klervie BAILLY principal investigator

Fondation Ildys

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiovascular Diseases (CVD) and Coronary Heart Disease (CHD), run by Fondation Ildys at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To compare the average heart rate between an active walking session and an orientation walking session during the cardiac rehabilitation stay. (time frame: once during the second and third week of cardiac rehabilitation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06941597.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.